NCT05774054View on ClinicalTrials.gov

The Impact of Early Norepinephrine Administration on Outcomes of Patients With Sepsis-induced Hypotension

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

February 1, 2023

Study Completion Date

March 10, 2023

Conditions
NorepinephrineSepsisHypotension
Interventions
DRUG

Crystalloid

received (30ml /kg) ringer's lactate solution after first presentation then norepinephrine was added when persistent mean arterial pressure (MAP)\> 65 mmHg despite adequate fluid resuscitation

DRUG

noradrenaline

received ( 30ml /kg) ringer's lactate solution after first presentation combined with norepinephrine infusion (0.05 mic/kg/min)

Trial Locations (1)

31111

Faculty of medicine, Tanta university, Tanta

All Listed Sponsors
lead

Tanta University

OTHER